Angios Biotech is an Austrian biotechnology company specializing in cell-based research focused on vascular diseases, utilizing induced pluripotent stem cells (iPSC) to develop novel therapies.

Angios Biotech

Angios FlexCo | 649 followers on LinkedIn. Novel approaches to vascular therapy | Angios is a biotechnology company, specializing in vascular research to improve patients&#39; lives all over the world. We are based in the beautiful city of Innsbruck. We strive to develop new treatments for challenging diabetic vascular diseases by pursuing pre-identified targets for diabetic retinopathy and by leveraging the vascular organoid model developed in the laboratories of our founders.

Senior Scientist

Azarakhsh Oladzad

Scientist & Lab Manager @ Angios GmbH | Ph.D. in Pharmaceutical Sciences & B.A. (MCI) in Business Administration | Digital Marketing enthusiast

Tanila Ben Haddou

Biotechnologin

Nicole Przysiecki

CEO & Founder bei Angios Flexco, Consultant to Life Sciences companies/investors

Gregor Wick

Angios FlexCo

Danke an alle, die uns bei der Langen Nacht der Forschung am 24.05 im CCB Innsbruck besucht haben! Wir sind begeistert, wie viele junge WissenschaftlerInnen sich für Organoidforschung interessieren.

Hands on with Angios at the Lange Nacht der Forschung!

Join us on Friday 24.05.2024 at the CCB Innsbruck for an exciting night of research.

Angios with partners from SWEEPICS consortium in our kick-off meeting in Lübeck. Check us out at www.sweepics.eu

Angios at the PhD Life science meeting in Innsbruck.

We are hiring! Check out the position on our website www.angios-bio.com

ANGI

COM:ANGIOS-BIO

Angios Biotech

Filings Not Available